Abstract

We provide a comprehensive review of the role of β-hydroxybutyrate (β-OHB), its linear polymer poly-β-hydroxybutyrate (PHB), and inorganic polyphosphate (polyP) in mammalian health and disease. β-OHB is a metabolic intermediate that constitutes 70% of ketone bodies produced during ketosis. Although ketosis has been generally considered as an unfavorable pathological state (e.g., diabetic ketoacidosis in type-1 diabetes mellitus), it has been suggested that induction of mild hyperketonemia may have certain therapeutic benefits. β-OHB is synthesized in the liver from acetyl-CoA by β-OHB dehydrogenase and can be used as alternative energy source. Elevated levels of PHB are associated with pathological states. In humans, short-chain, complexed PHB (cPHB) is found in a wide variety of tissues and in atherosclerotic plaques. Plasma cPHB concentrations correlate strongly with atherogenic lipid profiles, and PHB tissue levels are elevated in type-1 diabetic animals. However, little is known about mechanisms of PHB action especially in the heart. In contrast to β-OHB, PHB is a water-insoluble, amphiphilic polymer that has high intrinsic viscosity and salt-solvating properties. cPHB can form non-specific ion channels in planar lipid bilayers and liposomes. PHB can form complexes with polyP and Ca2+ which increases membrane permeability. The biological roles played by polyP, a ubiquitous phosphate polymer with ATP-like bonds, have been most extensively studied in prokaryotes, however polyP has recently been linked to a variety of functions in mammalian cells, including blood coagulation, regulation of enzyme activity in cancer cells, cell proliferation, apoptosis and mitochondrial ion transport and energy metabolism. Recent evidence suggests that polyP is a potent activator of the mitochondrial permeability transition pore in cardiomyocytes and may represent a hitherto unrecognized key structural and functional component of the mitochondrial membrane system.

Highlights

  • We provide a comprehensive review of the role of β-hydroxybutyrate (β-OHB), its linear polymer poly-β-hydroxybutyrate (PHB), and inorganic polyphosphate in mammalian health and disease. β-OHB is a metabolic intermediate that constitutes 70% of ketone bodies produced during ketosis

  • WHAT IS β-HYDROXYBUTYRATE? β-Hydroxybutyrate (β-OHB; known as 3-hydroxybutyric acid) is a metabolic intermediate that constitutes ∼70% of ketone bodies produced in liver mitochondria mainly from the oxidation of fatty acids released from adipose tissue (Persson, 1970)

  • AcAc and β-OHB are transported by blood to the extrahepatic tissues, where they are oxidized via the tricarboxylic acid (TCA) cycle to provide the energy required by tissues such as skeletal and heart muscle and the renal cortex (Figure 2)

Read more

Summary

Introduction

We provide a comprehensive review of the role of β-hydroxybutyrate (β-OHB), its linear polymer poly-β-hydroxybutyrate (PHB), and inorganic polyphosphate (polyP) in mammalian health and disease. β-OHB is a metabolic intermediate that constitutes 70% of ketone bodies produced during ketosis. Ketone body contribution to the overall energy metabolism in the heart and other extrahepatic tissues increases significantly after prolonged exercise, during fasting, adherence to low carbohydrate ketogenic diet (LCKD) and in the neonatal period (Veech et al, 2001; Veech, 2004). In these physiological situations, the concentration of circulating blood β-OHB rises from ∼0.1 mM observed in normal fed state to ∼1 mM after few hours of fasting, and www.frontiersin.org. This review discusses the roles of β-OHB, PHB, and inorganic polyP with specific focus on cardiovascular health and disease

Objectives
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call